Long Ideas - Sunshine Heart (SSH) in its quarterly earnings report and conference call on Wednesday provided anecdotal evidence that its C-Pulse device is benefitting late-stage heart failure … Continue Reading
Read nowLong Ideas - Synergy Pharmaceuticals (SGYP) announced – with little detail – a positive outcome from an end-of-Phase-II meeting with the FDA regarding plecanatide, Synergy’s Guanylate Cyclase-C agonist … Continue Reading
Read nowMost Popular - As we wrote in a note to PropThink Premium subscribers on Monday July 29 before the market open, an imbalance in the supply of stock … Continue Reading
Read nowLong Ideas - On Thursday, July 25th, Onconova Therapeutics (ONTX) makes its debut on the NASDAQ Global Market as the 27th biotech IPO of 2013. It’s been a … Continue Reading
Read nowLong Ideas - Ironwood Pharmaceuticals (IRWD) reported 2Q earnings on Tuesday morning, trouncing analyst estimates for sales of Linzess and assuaging a major overhang on the stock. The … Continue Reading
Read nowMost Popular - At the end of June, biotech giant Celgene (CELG) made a $15M investment in a small and obscure biotech for the right-of-first-negotiation to one of its lead … Continue Reading
Read nowInsights - Celsion (CLSN) has issued a glowing but arguably immaterial press release reminding investors that, yes, there is another company on earth that has a small … Continue Reading
Read now